Healthcare Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018

Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities


RELEASE DATE
04-Sep-2018
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
ME1D-01-00-00-00
SKU
HC03076-NA-MR_22287
Yes
SHARE

Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018
Published on: 04-Sep-2018 | SKU: HC03076-NA-MR_22287

Need more details?
$3,000.00
DownloadLink
Need more details?

The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally enabled by the entry of non-traditional tech companies such as Apple, Facebook, and Google—pushing pharmaceutical companies to go beyond-the-pill. However, in the midst of this chaos, there are pioneering companies offering solutions that apply cutting-edge digital technologies such as AI, Big Data and analytics, cloud, mobile, blockchain, and Internet of Things (IoT) to build digital convergence across the pharmaceutical value chain, covering R&D, manufacturing and operations, marketing, and patient connect. This Companies to Action (C2A) analysis puts the spotlight on such game-changing, tech-enabled participants and how they are altering the status-quo by highlighting novel monetization models and strategic investment opportunities.

Research Scope

The key objective of this study is to highlight current market dynamics, key market participants, customer segments, and evolving business opportunities. The study aims to identify pioneering companies that are capable of shaping the future through best practices implementation, visionary leadership, and innovation in business models. The company profiles offer insights around key solution offerings, target customer segments, service differentiators, and future growth strategies.

Further, the global study provides an analysis of companies segregated by market segments such as: smart R&D, flexible manufacturing, connected patients, and digital pharmacy. The analysis covers technologies such as Artificial intelligence (AI), Big Data and analytics, crowdsourcing, mobile, Industrial IoT (IIoT), IoT, cloud, blockchain, eCommerce, and so on.

The participants mentioned in the study are iSolve, Zephyr Health, PillPack, Proteus Digital Health, BenevolentAI, Elemental Machines, Exscientia, Science 37, Transparency Life Sciences, and uMotif. It also lists the wider universe of companies that were assessed for this analysis. These companies were chosen based factors such as innovative technology development and application, hitting the right focus areas, proven success and industry recognition, and enhanced client collaborations.

Key Issues Addressed

  • How are companies creating extraordinary value for pharmaceutical stakeholders?
  • Which are some unique companies that are introducing new and innovative solutions in the market?
  • How do these companies intend to transform the healthcare industry paradigms in the future? What is the impact of the external industry environment on this market?
  • What is their action plan and potential for growth? What are the current growth opportunities in digital transformation?
  • What are some key success factors in the pharmaceutical market?
  • Which are the companies with whom partnerships can be forged?

 

Key Findings

Methodology

Scope and Segmentation

Key Questions this Study will Answer

Pillars of Digital Transformation and Growth Opportunity in Pharmaceuticals

Tackling Challenges in the Pharmaceuticals Industry

Major Challenges Limiting Digital Transformation

Companies-to-Action Value Creators

Threats and Opportunities

Strategic Imperatives for Digital Transformation in Pharmaceuticals

Definition and Solution Segmentation

Impact of Key Market Influencers

Pillars of Digital Transformation and Vendor Strategies

C2A Targets Aligned With Pillars of Digital Transformation

Value Chain Analysis

Benchmarking of Top Companies-to-Action

BenevolentAI

BenevolentAI (continued)

Exscientia

Exscientia (continued)

Science 37

Science 37 (continued)

Transparency Life Science

Transparency Life Sciences (continued)

Elemental Machines

Elemental Machines (continued)

iSolve

iSolve (continued)

PillPack

PillPack (continued)

Zephyr Health

Zephyr Health (continued)

Proteus Digital Health

Proteus Digital Health (continued)

uMotif

uMotif (continued)

Building Life Science Digital Capabilities by Innovation Tracking

Conclusion—Key Takeaways From the Companies-to-Action Analysis

Legal Disclaimer

List of Vendors Assessed

List of Vendors Assessed (continued)

List of Vendors Assessed (continued)

List of Vendors Assessed (continued)

List of Vendors Assessed (continued)

List of Vendors Assessed (continued)

List of Vendors Assessed (continued)

List of Vendors Assessed (continued)

List of Exhibits

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related industry research

17 Sep 2026   |   Asia Pacific   |   Frost Radar

Frost Radar™: Facility Management in Malaysia, 2026

Malaysia's facility management (FM) market is transitioning from labor-intensive, compliance-driven service delivery to technology-enabled, outcome-oriented, and sustainability-integrated operating models. Competitive differentiation increasingly depends on providers’ ability to combine integrated F...

17 Sep 2026   |   Global   |   Market Research

Growth Opportunities in the Western Europe Consumer eSIM Market, 2026–2029

The consumer eSIM market in Western Europe is growing steadily, supported by the rising availability of eSIM-capable devices, particularly smartphones, and expanding travel-related use cases. However, commercialization has yet to translate into mass adoption. Despite Apple’s global launch of an eSIM...

17 Sep 2026   |   Asia Pacific   |   Frost Radar

Frost Radar™: ASEAN Warehouse Automation System Providers, 2026

Warehouse automation has moved from a discretionary capital project to a core operating capability. ASEAN operators are redesigning fulfillment networks around smaller orders, shorter delivery windows, broader stock keeping unit (SKU) ranges, and sharper demand volatility. Manual operations remain v...

16 Sep 2026   |   North America   |   Customer Research

US Automotive Technicians’ Choice Survey, 2025

The 2025 US Automotive Technicians’ Choice study is an insightful voice-of-customer survey that highlights the tool preferences of automotive aftermarket service technicians. The survey of 400 automotive technicians across the United States used a combination of computer-assisted telephone and compu...

16 Sep 2026   |   Global   |   Market Research

Apple Performance Tracker, Q1 2026

This Frost & Sullivan tracker provides metrics on Apple's quarterly performance (for both unit sales and revenues) for iPads, iPhones, Macs, and other products, such as iPods, Apple TVs, Beats Electronics, and Apple-branded and third-party accessories. It includes historical quarterly data for all t...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally enabled by the entry of non-traditional tech companies such as Apple, Facebook, and Google—pushing pharmaceutical companies to go beyond-the-pill. However, in the midst of this chaos, there are pioneering companies offering solutions that apply cutting-edge digital technologies such as AI, Big Data and analytics, cloud, mobile, blockchain, and Internet of Things (IoT) to build digital convergence across the pharmaceutical value chain, covering R&D, manufacturing and operations, marketing, and patient connect. This Companies to Action (C2A) analysis puts the spotlight on such game-changing, tech-enabled participants and how they are altering the status-quo by highlighting novel monetization models and strategic investment opportunities.--BEGIN PROMO--

Research Scope

The key objective of this study is to highlight current market dynamics, key market participants, customer segments, and evolving business opportunities. The study aims to identify pioneering companies that are capable of shaping the future through best practices implementation, visionary leadership, and innovation in business models. The company profiles offer insights around key solution offerings, target customer segments, service differentiators, and future growth strategies.

Further, the global study provides an analysis of companies segregated by market segments such as: smart R&D, flexible manufacturing, connected patients, and digital pharmacy. The analysis covers technologies such as Artificial intelligence (AI), Big Data and analytics, crowdsourcing, mobile, Industrial IoT (IIoT), IoT, cloud, blockchain, eCommerce,

More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Neelotpal Goswami
Industries Healthcare
WIP Number ME1D-01-00-00-00
Is Prebook No
GPS Codes 9562-B1,9564-B1,9568-B1,9571-B1,9573-B1,9575-B1,9600-B1,9611-B1,9612-B1,9627-B1,99BC-B1,99C1-B1,99C6-B1,9A42-B1,9A43-B1,9A44-B1,9A4E-B1

Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018

$3,000.00
In stock
SKU
HC03076-NA-MR_22287